humanitarian Archived signal

Human medicines European public assessment report (EPAR): Ratiograstim, filgrastim, Date of authorisation: 15/09/2008, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR): Daybu, trofinetide, Date of authorisation: 20/08/2026, Revision: 1, Status: Authorised

Reported by EMA What Is New Oct 15, 2026 · 14:12 UTC

Read the complete report at EMA What Is New ↗

Verification notice

IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.

INCIDENT FUSION

12 reports · 2 sources

EMA What Is NewHuman medicines European public assessment report (EPAR): Ratiograstim, filgrastim, Date of authorisation: 15/09/2008, Revision: 18, Status: Authorised14:12 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Ratiograstim, filgrastim, Date of authorisation: 15/09/2008, Revision: 18, Status: Authorised14:12 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Tevagrastim, filgrastim, Date of authorisation: 15/09/2008, Revision: 20, Status: Authorised14:08 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Tevagrastim, filgrastim, Date of authorisation: 15/09/2008, Revision: 20, Status: Authorised14:08 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Elaprase, idursulfase, Date of authorisation: 08/01/2007, Revision: 28, Status: Authorised14:04 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Elaprase, idursulfase, Date of authorisation: 08/01/2007, Revision: 28, Status: Authorised14:04 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Mirvaso, brimonidine, Date of authorisation: 20/02/2014, Revision: 15, Status: Authorised14:02 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Mirvaso, brimonidine, Date of authorisation: 20/02/2014, Revision: 15, Status: Authorised14:02 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Rasonque, Daraxonrasib, Status: Opinion13:35 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Rasonque, Daraxonrasib, Status: Opinion13:35 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Cabometyx, cabozantinib, Date of authorisation: 09/09/2016, Revision: 21, Status: Authorised12:42 UTC EMA What Is NewHuman medicines European public assessment report (EPAR): Cabometyx, cabozantinib, Date of authorisation: 09/09/2016, Revision: 21, Status: Authorised12:42 UTC

INCIDENT EVOLUTION

2 recorded states

Oct 15 · 14:26 UTC

Signal first indexedP2 · 99% quality · 2 sources

Oct 15 · 14:31 UTC

Headline updatedP2 · 99% quality · 2 sources

Explore this day in the archive →